Shares of Schrodinger Inc (NYSE:SDGR) have earned an average broker rating score of 2.50 (Hold) from the four brokers that provide coverage for the stock, Zacks Investment Research reports. Three research analysts have rated the stock with a hold recommendation and one has given a strong buy recommendation to the company.
Brokerages have set a 12 month consensus price target of $57.25 for the company and are forecasting that the company will post ($0.25) EPS for the current quarter, according to Zacks. Zacks has also given Schrodinger an industry rank of 69 out of 254 based on the ratings given to its competitors.
NYSE SDGR opened at $69.17 on Friday. The stock’s fifty day moving average price is $48.17. Schrodinger has a 52 week low of $25.50 and a 52 week high of $72.49.
Schrodinger Company Profile
Schrödinger, Inc provides computational platform to accelerate drug discovery and materials design for biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. The company operates through two segments, Software and Drug Discovery. It segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries.
Featured Story: Limitations to arbitrage trading
Get a free copy of the Zacks research report on Schrodinger (SDGR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.